Community Surveys Show Enthusiasm for Long-Acting Hepatitis C Cure Research
“People living with or at risk of hepatitis C virus (HCV), health care providers, and policymakers in low- and middle-income countries (LMICs) showed significant interest in a potential long-acting HCV cure, recent surveys have found.”
Patients With HIV Coinfection More Likely to Clear HCV
“A retrospective cohort study published in Open Forum Infectious Diseases analyzed surveillance data obtained between 2015 and 2021 to assess the impact of HIV coinfection and Ryan White (RW) HIV care on hepatitis C virus (HCV) clearance. Marissa Tan, DO, MPH, and colleagues found that among 10,251 patients with newly reported HCV, 353 patients (3.4%) had HIV coinfection. Patients with HIV were more likely to achieve HCV clearance than those with HCV monoinfection (adjusted HR, 1.2; 95% CI, 1.1–1.4; P<0.05).”
Talal to Be Honored With 2025 Top Ten Clinical Research Achievement Award
“A novel approach developed by a UB physician-scientist and colleagues to cure hepatitis C virus in people with opioid use disorder using facilitated telemedicine is being honored with a 2025 Top Ten Clinical Research Achievement Award from the Clinical Research Forum.”
Renowned geneticist Francis Collins retires from NIH, urging ‘respect’ for embattled workers
“WASHINGTON (AP) — Dr. Francis Collins, a renowned geneticist and former longtime director of the National Institutes of Health, announced Saturday that he has retired, leaving an agency being upended by budget cuts and layoffs.”
Hepatitis C test guidelines led to more screenings in women, especially in pregnancy, but not enough
“Screening per 1,000 person-years increased from 141 to 253 in pregnant women and from 29 to 37 in nonpregnant women. By December 2022, 38.7% of pregnant women and 8.7% of nonpregnant women had ever been tested for HCV. At the same time, 90.4% of pregnant women had been tested for HIV.”
